Monte Rosa Therapeutics Inc (GLUE)
CapEx to Revenue
52.67%
Quarterly · Period ending:
GLUE CapEx to Revenue
Latest reported52.67%period ending
Latest reported52.67%period ending
GLUE Quarterly CapEx/Revenue (0.00% → 52.67%)
Latest values, visible window
High-resolution chart · PNG
GLUE capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 52.665% | |
| 44.3705% | |
| 27.58% | |
| 5.0987% | |
| 7.3079% | |
| 1.8686% | |
| 0.3017% | |
| 4.3294% | |
| 43.0671% | |
| 130.0752% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |